- Home
- SENS vs RZLT Comparison
SENS vs RZLT Comparison
Compare SENS & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENS
- RZLT
- Stock Information
- Founded
- SENS 1996
- RZLT 2010
- Country
- SENS United States
- RZLT United States
- Employees
- SENS N/A
- RZLT N/A
- Industry
- SENS Industrial Machinery/Components
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- SENS Industrials
- RZLT Health Care
- Exchange
- SENS Nasdaq
- RZLT Nasdaq
- Market Cap
- SENS 372.6M
- RZLT 361.3M
- IPO Year
- SENS N/A
- RZLT N/A
- Fundamental
- Price
- SENS $0.47
- RZLT $7.20
- Analyst Decision
- SENS Strong Buy
- RZLT Strong Buy
- Analyst Count
- SENS 5
- RZLT 5
- Target Price
- SENS $1.63
- RZLT $12.50
- AVG Volume (30 Days)
- SENS 4.8M
- RZLT 680.6K
- Earning Date
- SENS 08-06-2025
- RZLT 09-18-2025
- Dividend Yield
- SENS N/A
- RZLT N/A
- EPS Growth
- SENS N/A
- RZLT N/A
- EPS
- SENS N/A
- RZLT N/A
- Revenue
- SENS $25,466,000.00
- RZLT N/A
- Revenue This Year
- SENS $63.52
- RZLT N/A
- Revenue Next Year
- SENS $67.91
- RZLT N/A
- P/E Ratio
- SENS N/A
- RZLT N/A
- Revenue Growth
- SENS 5.94
- RZLT N/A
- 52 Week Low
- SENS $0.25
- RZLT $2.22
- 52 Week High
- SENS $1.40
- RZLT $7.46
- Technical
- Relative Strength Index (RSI)
- SENS 45.64
- RZLT 78.84
- Support Level
- SENS $0.43
- RZLT $6.23
- Resistance Level
- SENS $0.47
- RZLT $6.64
- Average True Range (ATR)
- SENS 0.02
- RZLT 0.30
- MACD
- SENS 0.00
- RZLT 0.05
- Stochastic Oscillator
- SENS 51.35
- RZLT 86.56
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.